Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy

Oncology

Volumn 60, Issue 1, 2001, Pages 88-93

  Pronzato, Paolo ^a,b   Queirolo, Paola ^c   Vecchio, Stefania ^b   Lionetto, Rita ^c   Del Mastro, Lucia ^c   Venturini, Marco ^c   Gardin, Giovanni ^c   Alama, Angela ^c   Sertoli, Mario R ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Breast cancer; Chemotherapy, perioperative; Thymidine labeling index

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; TAMOXIFEN; THYMIDINE;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; HUMAN; LABELING INDEX; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TUMOR CELL CULTURE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; RISK; RISK FACTORS; SURVIVAL ANALYSIS; THYMIDINE;

EID: 0035170003     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055302     Document Type: Article

References (18)

1. Karnofsky memorial lecture: Conceptual and practical advances in the management of breast cancer
2. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy
3. Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer
4. Immunohistochemical assay for epidermal growth factor receptors on paraffin-embedded sections: Validation against ligand binding assay and clinical relevance in breast cancer
5. Identification of low-risk group of stage I breast cancer patients by cytometrically assessed DNA and nuclear texture parameters
6. Factors affecting relapse in node-negative breast cancer. A multivariate analysis including the labeling index
7. Breast cancer angiogenesis: Therapy target and prognostic factor
8. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer
9. Cell biological factors associated with response of breast cancer to systemic treatment
10. Proliferative index of breast carcinoma by thymidine labeling: Prognostic power independent of stage, estrogen and progesterone receptors
11. Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer
12. Thymidine labeling index and Ki-67 growth fraction in breast cancer: Comparison and correlation with prognosis
13. Chemotherapy with estrogenic recruitment and surgery in locally advanced breast cancer: Clinical and cytokinetic results
14. Randomized cooperative study of perioperative chemotherapy in breast cancer
15. Thymidine labeling index as prognostic factor in resected non-small cell lung cancer
16. Relationship of variation in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer
17. Cell kinetics as a prognostic indicator in node-negative breast cancer
18. Overview of randomized perioperative polychemotherapy trials in women with early-stage breast cancer